The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults

Diabetes Care

Volumn 30, Issue 4, 2007, Pages 980-986

  Pittas, Anastassios G ^a   Harris, Susan S ^b   Stark, Paul C ^a   Dawson Hughes, Bess ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CITRATE CALCIUM; COLECALCIFEROL; GLUCOSE; INSULIN; INTERLEUKIN 6; PLACEBO;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POST HOC ANALYSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INSULIN; MALE; REFERENCE VALUES; VITAMIN D;

EID: 34147190196     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1994     Document Type: Article

References (58)

1. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782-787, 2001
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesityrelated health risk factors, 2001. JAMA 289:76 -79, 2003
3. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790-797, 2001
4. Wing RR, Phelan S: Long-term weight loss maintenance. Am J Clin Nutr 82 (Suppl. 1):222S-225S, 2005
5. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E: Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 27:181-188, 1995
6. Isaia G, Giorgino R, Adami S: High prevalence of hypovitaminosis D in female type 2 diabetic population (Letter). Diabetes Care 24:1496, 2001
7. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2813-2818, 2004
8. Need AG, O'Loughlin PD, Horowitz M, Nordin BE: Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 62:738 -741, 2005
9. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820-825, 2004
10. Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28:1228-1230, 2005
11. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G: Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29:722-724, 2006
12. McCarron DA, Morris CD, Henry HJ, Stanton JL: Blood pressure and nutrient intake in the United States. Science 224: 1392-1398, 1984
13. Lind L, Lithell H, Hvarfner A, Pollare T, Ljunghall S: On the relationships between mineral metabolism, obesity and fat distribution. Eur J Clin Invest 23:307-310, 1993
14. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S: Calcium intake and body weight. J Clin Endocrinol Metab 85:4635-4638, 2000
15. Lovejoy JC, Champagne CM, Smith SR, de Jonge L, Xie H: Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: the Healthy Transitions Study. Am J Clin Nutr 74:90-95, 2001
16. Jacqmain M, Doucet E, Despres JP, Bouchard C, Tremblay A: Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr 77:1448-1452, 2003
17. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, Hu FB: Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650-656, 2006
18. Gedik O, Akalin S: Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29:142-145, 1986
19. Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S: Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance: effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 11:141-147, 1989
20. Orwoll E, Riddle M, Prince M: Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59:1083-1087, 1994
21. Heaney RP, Davies KM, Barger-Lux MJ: Calcium and weight: clinical studies. J Am Coll Nutr 21:152S-155S, 2002
22. Gunther CW, Legowski PA, Lyle RM, McCabe GP, Eagan MS, Peacock M, Teegarden D: Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. Am J Clin Nutr 81:751-756, 2005
23. Zofkova I, Stolba P: Effect of calcitriol and trifluoperazine on glucose stimulated B cell function in healthy humans. Exp Clin Endocrinol 96:185-191, 1990
24. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E: No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 27:629-633, 1997
25. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R: The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258-261, 2003
26. Zemel MB, Thompson W, Milstead A, Morris K, Campbell P: Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 12:582-590, 2004
27. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676, 1997
28. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J: Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 76:470-473, 1985
29. Harris SS: Vitamin D and African Americans. J Nutr 136:1126-1129, 2006
30. American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 28 (Suppl. 1):S37-S42, 2005
31. Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson-Hughes B: Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 321:1777-1783, 1989
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
33. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
34. Garcia-Estevez DA, Araujo-Vilar D, Fiestras-Janeiro G, Saavedra-Gonzalez A, Cabezas-Cerrato J: Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices. Horm Metab Res 35:13-17, 2003
35. Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB, Supiano MA: Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people. J Clin Endocrinol Metab 91:629-634, 2006
36. Washburn RA, Smith KW, Jette AM, Janney CA: The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153-162, 1993
37. Preece MA, O'Riordan JL, Lawson DE, Kodicek E: A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum. Clin Chim Acta 54:235-242, 1974
38. Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB: Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 165:997-1003, 2005
39. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM: Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:2926-2932, 2005
40. Pittas AG, Joseph NA, Greenberg AS: Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89:447- 452, 2004
41. Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333-1346, 2005
42. Norman AW, Frankel JB, Heldt AM, Grodsky GM: Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823-825, 1980
43. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF: Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113:1511-1518, 1983
44. Soliman AT, Aref MK, Rogol AD: Arginine-induced insulin and growth hormone secretion in children with nutritional rickets. J Pediatr Gastroenterol Nutr 6:589 -592, 1987
45. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D: Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40:344 -347, 1997
46. Tanaka Y, Seino Y, Ishida M, Yamaoka K, Yabuuchi H, Ishida H, Seino S, Seino Y, Imura H: Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol (Copenh) 105:528-533, 1984
47. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T: Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner 1:187-192, 1986
48. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M: Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90:121-125, 2004
49. Taylor AV, Wise PH: Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 74:365-366, 1998
50. Kumar S, Davies M, Zakaria Y, Mawer EB, Gordon C, Olukoga AO, Boulton AJ: Improvement in glucose tolerance and betacell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J 70:440-443, 1994
51. Zemel MB: Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 188:129-136, 1998
52. Fujita T, Palmieri GM: Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 18:109-125, 2000
53. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercome-Court D, Aganna E, Price CP, Boucher BJ: Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Qjm 95:787-796, 2002
54. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R: Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88:4623-4632, 2003
55. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754 -759, 2006
56. Food and Nutrient Board IoM: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC, National Academy Press, 1997
57. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R: Estimates of optimal vitamin D status. Osteoporos Int 16:713-716, 2005
58. Heaney RP: The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97:13-19, 2005